Messenger ribonucleic acid — known as mRNA — was discovered in the 1960s, but it has reached new heights of popularity among vaccine developers due to its flexibility and adaptability to emerging infectious diseases.
Now, scientists are exploring the potential for mRNA to combat diseases that have long burdened the world’s poorest communities. A Spotlight series, produced by SciDev.Net’s Global desk, explores the development of mRNA vaccines for the Big Three deadliest infectious diseases – TB, malaria, and HIV/AIDS.
The Spotlight series ‘The new frontier’ can be accessed here.
Source : SciDev.Net
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.